News
Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...
While Trump has been wildly inconsistent on his plans for reciprocal tariffs, levies on imported pharmaceuticals appear to be ...
It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, ...
Peter R. Orszag, the C.E.O. of Lazard, discusses how markets are reacting to the uncertainty of Trump’s tariffs.
The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.
2d
Investor's Business Daily on MSNTrump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.Robert F. Kennedy Jr. is the new Health Secretary. From fluoride, vaccines and beef tallow, here's how he might "go wild" on ...
3d
inews.co.uk on MSNWeight-loss jabs could face price rises and shortages due to Trump’s trade warTrump’s latest tariff vow threatens to disrupt supplies of obesity drugs such as Mounjaro and Wegovy as pharma giants face ...
When David Bergeron went to work at the office that would become the Department of Education nearly 50 years ago, higher-ups pointed him to a provision that barred staffers from getting involved ...
BUFFALO, N.Y. — President Trump brought up the subject of tariffs for the overseas pharmaceutical industry at a D.C. dinner for Republican members of Congress on Tuesday night.
The U.S. does not buy drugs directly for a national health system, as countries such as England and Germany do, instead ...
U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results